Does Inlyta have generic?
No. There is currently no therapeutically equivalent version of Inlyta available in the United States. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Inlyta. These medications may be counterfeit and potentially unsafe.
What is the brand name for axitinib?
Axitinib, sold under the brand name Inlyta, is a small molecule tyrosine kinase inhibitor developed by Pfizer.
Is Inlyta FDA approved?
FDA Approves BAVENCIO® (avelumab) Plus INLYTA® (axitinib) Combination for Patients with Advanced Renal Cell Carcinoma | Pfizer.
Is Inlyta a chemo drug?
Axitinib (Inlyta®) is a Chemotherapy Regimen for Renal Cell Carcinoma – Kidney Cancer.
What is the cost of inlyta?
The cost for Inlyta oral tablet 1 mg is around $17,370 for a supply of 180 tablets, depending on the pharmacy you visit….Oral Tablet.
| Quantity | Per unit | Price |
|---|---|---|
| 60 | $289.49 | $17,369.55 |
Does inlyta cause hair loss?
Inlyta may cause hair loss (also called alopecia) in some people.
Who makes sunitinib?
Sunitinib is marketed by Pfizer as Sutent, and is subject to patents and market exclusivity as a new chemical entity until February 15, 2021.
Is axitinib a tablet?
Axitinib comes as a tablet to take by mouth. It is usually taken with or without food two times a day. Take axitinib at around the same times every day, about 12 hours apart.
What are the side effects of inlyta?
Nausea, vomiting, loss of appetite, dizziness, tiredness/weakness, weight loss, temporary hair loss, cough, headache, altered sense of taste, hoarseness, constipation, or upset stomach may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
Does Inlyta cause hair loss?
How long does Inlyta prolong life?
Study participants were assigned to treatment with either Inlyta or Nexavar® (sorafenib). Inlyta delayed the worsening of the cancer: progression-free survival was 6.7 months among patients treated with Inlyta and 4.7 months among patients treated with Nexavar.
Is axitinib available in India?
Karnataka: Shilpa Medicare Limited has launched the Indian branded generic of Axitinib, a tyrosine kinase inhibitor drug with a brand name AXISHIL. AXISHIL is available as 1 mg & 5 mg tablets in a pack of 14’s Tablets in one bottle. AXISHIL is used to treat patients suffering from Advanced Renal Cell Carcinoma (RCC).
https://www.youtube.com/watch?v=MeLimVJom_0